Moderna says FDA needs more time to complete review of its COVID-19 shot for adolescents By Reuters
Moderna, Inc.: EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Authorization Of Moderna's Omicron BA.4-BA.5 Targeting Bivalent Covid-19 Vaccine In The European Union
Coronavirus: US relaxes vaccine guidance to allow more time between doses – as it happened | Financial Times